Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
mrepo:insight [10/12/2019 @ 08:39]
127.0.0.1 external edit
mrepo:insight [09/01/2020 @ 10:44] (current)
adammoore
Line 24: Line 24:
 === Accessing Insight 46 data === === Accessing Insight 46 data ===
 ---- ----
-Much of the Insight 46 data collected at the first wave of clinic visits is available via [[skylark:​skylark|Skylark]],​ and access to these data can be [[nshd:​forms | requested]] in the same way as for the other NSHD variables. \\ \\ The Insight 46 datasets currently include, but are not limited to:+Most of the Insight 46 data collected at the first wave of clinic visits is available via [[skylark:​skylark|Skylark]],​ and access to these data can be [[nshd:​forms | requested]] in the same way as for the other NSHD variables. \\ \\    The Insight 46 datasets currently include, but are not limited to:
    
   * {{apoe.pdf|ApoE status }}   * {{apoe.pdf|ApoE status }}
Line 34: Line 34:
   *  Cognitive test results - including {{ad8.pdf|ad8}},​ {{mci.pdf|mci}},​ {{scd_mycog.pdf|scd and MyCog}}, {{mmse.pdf|mmse}} and others ​   *  Cognitive test results - including {{ad8.pdf|ad8}},​ {{mci.pdf|mci}},​ {{scd_mycog.pdf|scd and MyCog}}, {{mmse.pdf|mmse}} and others ​
   *  {{Audiometry.pdf|Audiometry}}  ​   *  {{Audiometry.pdf|Audiometry}}  ​
-\\ \\ +\\  
 +For a quick way to view all available variables from the Insight 46 neuroscience sub-study, <​HTML><​a href="​https://​skylark.ucl.ac.uk/​Skylark/​login">​ 1) log into Skylark</​a></​HTML> ​  2) make a **Year** search ​ \\  3) select **'​2016'​**  ​\\ \\
 ---- ----
 Insight 46 was funded by Alzheimer’s Research UK, MRC Dementias Platform UK, The Wolfson Foundation, Weston Brain Institute, Brain Research UK, and British Heart Foundation. The 18F Florbetapir amyloid PET tracer was provided by AVID Radiopharmaceuticals,​ a wholly owned subsidiary of Eli Lilly. Insight 46 was funded by Alzheimer’s Research UK, MRC Dementias Platform UK, The Wolfson Foundation, Weston Brain Institute, Brain Research UK, and British Heart Foundation. The 18F Florbetapir amyloid PET tracer was provided by AVID Radiopharmaceuticals,​ a wholly owned subsidiary of Eli Lilly.